Lipodystrophy Global Clinical Trials Review, H1, 2014 - KHGI-TV/KWNB-TV/KHGI-CD-Grand Island, Kearney, Hastings

Lipodystrophy Global Clinical Trials Review, H1, 2014

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, May 29, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Lipodystrophy Global Clinical Trials Review, H1, 2014

http://www.reportlinker.com/p02127363/Lipodystrophy-Global-Clinical-Trials-Review-H1-2014.html

Lipodystrophy Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Lipodystrophy Global Clinical Trials Review, H1, 2014" provides data on the Lipodystrophy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lipodystrophy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lipodystrophy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Introduction 6
Lipodystrophy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Lipodystrophy to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Lipodystrophy to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Lipodystrophy 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Lipodystrophy Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Lipodystrophy 31
May 06, 2013: Bristol-Myers Squibb And AstraZeneca Announce Positive Results From Sub-Group Analysis Of Metreleptin In Pediatric Patients With Lipodystrophy 31
Apr 15, 2011: Amylin To Present Data Showing Investigational Metreleptin Treatment Led To Long-Term Improvements In Diabetes And Lipid Control In Patients With Lipodystrophy 32
Jul 18, 2007: Theratechnologies TH9507 Phase III Clinical Update At International HIV Meeting 32
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Bristol-Myers Squibb Company 34
Clinical Trial Overview of Bristol-Myers Squibb Company 34
Theratechnologies Inc. 35
Clinical Trial Overview of Theratechnologies Inc. 35
Gilead Sciences, Inc. 36
Clinical Trial Overview of Gilead Sciences, Inc. 36
Merck KGaA 37
Clinical Trial Overview of Merck KGaA 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Sigma-Tau S.p.A. 39
Clinical Trial Overview of Sigma-Tau S.p.A. 39
Eli Lilly and Company 40
Clinical Trial Overview of Eli Lilly and Company 40
Cryopraxis Criobiologia Ltda 41
Clinical Trial Overview of Cryopraxis Criobiologia Ltda 41
AbbVie Inc. 42
Clinical Trial Overview of AbbVie Inc. 42
Clinical Trial Overview of Top Institutes / Government 43
The National Institute of Allergy and Infectious Diseases 43
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 43
The National Institute of Diabetes and Digestive and Kidney Diseases 44
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 44
The University of Texas Southwestern Medical Center at Dallas 45
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 45
French National Agency for Research on AIDS and Viral Hepatitis 46
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 46
The Kirby Institute 47
Clinical Trial Overview of The Kirby Institute 47
Massachusetts General Hospital 48
Clinical Trial Overview of Massachusetts General Hospital 48
Queen's University 49
Clinical Trial Overview of Queen's University 49
Beth Israel Deaconess Medical Center 50
Clinical Trial Overview of Beth Israel Deaconess Medical Center 50
Kyoto University 51
Clinical Trial Overview of Kyoto University 51
Hvidovre University Hospital 52
Clinical Trial Overview of Hvidovre University Hospital 52
Five Key Clinical Profiles 53
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 111

List of Tables

Lipodystrophy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Lipodystrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Lipodystrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Lipodystrophy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Lipodystrophy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Lipodystrophy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Lipodystrophy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Lipodystrophy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Lipodystrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Lipodystrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Lipodystrophy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Lipodystrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Lipodystrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Lipodystrophy Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Lipodystrophy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Lipodystrophy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Lipodystrophy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Lipodystrophy Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Lipodystrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Lipodystrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Lipodystrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Lipodystrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Lipodystrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 34
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Theratechnologies Inc., 2014* 35
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 36
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2014* 37
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau S.p.A., 2014* 39
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 40
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cryopraxis Criobiologia Ltda, 2014* 41
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 42
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 43
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 44
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2014* 45
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014* 46
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Kirby Institute, 2014* 47
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 48
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014* 49
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2014* 50
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014* 51
Lipodystrophy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2014* 52

List of Figures

Lipodystrophy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Lipodystrophy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Lipodystrophy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Lipodystrophy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Lipodystrophy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Lipodystrophy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Lipodystrophy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Lipodystrophy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Lipodystrophy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Lipodystrophy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Lipodystrophy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Lipodystrophy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Lipodystrophy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Lipodystrophy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Lipodystrophy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Lipodystrophy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Lipodystrophy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Lipodystrophy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Lipodystrophy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Lipodystrophy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Lipodystrophy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 110

To order this report: Lipodystrophy Global Clinical Trials Review, H1, 2014
http://www.reportlinker.com/p02127363/Lipodystrophy-Global-Clinical-Trials-Review-H1-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
General and news information or questions:
Across the Midlands Information:
events@nebraska.tv
Comments: comments@nebraska.tv
News:
news@nebraska.tv
Phone: 308-743-2494
News Fax: 308-743-2660
All content © Copyright 2000 - 2014 WorldNow and NTV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.